Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Institut Curie
Incyte Corporation
M.D. Anderson Cancer Center
Exelixis
ARCAGY/ GINECO GROUP
Fate Therapeutics
Incyte Corporation